4//SEC Filing
Mandel-Brehm Josh 4
Accession 0001104659-24-108699
CIK 0001736730other
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 5:45 PM ET
Size
7.2 KB
Accession
0001104659-24-108699
Insider Transaction Report
Form 4
Mandel-Brehm Josh
DirectorChief Executive Officer
Transactions
- Conversion
Series B Preferred Stock
2024-10-15−6,791→ 0 total→ Common Stock (605 underlying) - Conversion
Common Stock
2024-10-15+605→ 272,357 total
Footnotes (1)
- [F1]On October 15, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 11.2158-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering.
Documents
Issuer
Camp4 Therapeutics Corp
CIK 0001736730
Entity typeother
Related Parties
1- filerCIK 0001927058
Filing Metadata
- Form type
- 4
- Filed
- Oct 14, 8:00 PM ET
- Accepted
- Oct 15, 5:45 PM ET
- Size
- 7.2 KB